govt.fyi
Back to SB 34
Oklahoma Legislature· SB 34Second Reading referred to Business and Insurance

An act relating to prescription drugs, the official text

Shown verbatim: the complete text as captured from the official PDF posted by the Oklahoma Legislature, fetched 2026-07-23. Page and line markers are part of the official record; nothing is edited or removed. The official bill page.
1                              STATE OF OKLAHOMA

1

2                 1st Session of the 60th Legislature (2025)

2

3 SENATE BILL 34               By: Hicks
3

4

4

5

5

6                              AS INTRODUCED

6

7   An Act relating to prescription drugs; creating the

7   Access to Lifesaving Medicines Act; providing short

8   title; defining terms; prohibiting certain insurers

8   and pharmacy benefits managers from imposing certain

9   costs; requiring certain rebates be offered to

9   certain health benefit plans; establishing terms of

10  prescription drug cost sharing; directing

10  promulgation of rules; providing for noncodification;

11  providing for codification; and providing an

11  effective date.

12

12

13

13

14 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
14

15  SECTION 1.    NEW LAW      A new section of law not to be

15

16 codified in the Oklahoma Statutes reads as follows:
16

17  This act shall be known and may be cited as the "Access to

17

18 Lifesaving Medicines Act".
18

19  SECTION 2.    NEW LAW      A new section of law to be codified

19

20 in the Oklahoma Statutes as Section 6970 of Title 36, unless there
20

21 is created a duplication in numbering, reads as follows:
21

22  As used in this section:

22

23  1. "Adjusted out-of-pocket amount" means the copayment,

23

24 coinsurance, or other cost-sharing obligation that a health benefit
24

    Req. No. 679                                              Page 1
1 plan requires an insured to pay at the point of sale for a covered
1

2 prescription medication otherwise payable, less the pro rata portion
2

3 of any discounts, rebates, and price concessions in connection with
3

4 the prescription drug;
4

5   2. "Claim" means any bill, claim, or proof of loss made by or

5

6 on behalf of an insured or a provider to a health insurer or its
6

7 intermediary, administrator, or representative, with which the
7

8 provider has a provider contract for payment for health care
8

9 services under any health benefit plan;
9

10  3. "Excess cost burden" means any copayments, coinsurance, or

10

11 other cost-sharing an insured is required to pay at the point of
11

12 sale to receive a prescription drug or device that exceeds the
12

13 health insurer's or pharmacy benefits manager's net cost after
13

14 applying a pro rata portion of any discounts, rebates, or
14

15 concessions received from manufacturers, pharmacies, or other third
15

16 parties;
16

17  4. "Health benefit plan" means a health benefit plan as defined

17

18 pursuant to Section 6060.4 of Title 36 of the Oklahoma Statutes;
18

19  5. "Health care provider" or "provider" means a health care

19

20 provider as defined pursuant to Section 3090.2 of Title 63 of the
20

21 Oklahoma Statutes;
21

22  6. "Health insurer" means any entity subject to the

22

23 jurisdiction of the Insurance Department and the insurance laws and
23

24 regulations of this state that contracts or offers to contract to
24

    Req. No. 679                                              Page 2
1 provide, deliver, arrange for, pay for, or reimburse any of the
1

2 costs of health care services including, but not limited to, a
2

3 health maintenance organization, a health benefit plan, or any other
3

4 entity providing a plan of health insurance, health benefits, or
4

5 health care services;
5

6   7. "Maximum allowable claim" means the amount the health

6

7 insurer or pharmacy benefits manager has agreed to pay a pharmacy;
7

8   8. "Maximum allowable cost" means the maximum dollar amount

8

9 that a health insurer or its intermediary will reimburse a pharmacy
9

10 provider for a group of drugs rated as "A", "AB", "NR", or "NA" in
10

11 the most recent edition of the Approved Drug Products with
11

12 Therapeutic Equivalence Evaluations, published by the United States
12

13 Food and Drug Administration, or similarly rated by a nationally
13

14 recognized reference;
14

15  9. "Pharmacy" means a pharmacy as defined pursuant to Section

15

16 353.1 of Title 59 of the Oklahoma Statutes;
16

17  10. "Pharmacy benefits manager" means a pharmacy benefits

17

18 manager as defined pursuant to Section 6960 of Title 36 of the
18

19 Oklahoma Statutes;
19

20  11. "Point of sale" means the transaction in which goods or

20

21 services including, but not limited to, prescription medications,
21

22 medical devices, and medical supplies are sold to the consumer;
22

23  12. "Rebate" means:

23

24

24

    Req. No. 679                                               Page 3
1   a. negotiated price concessions including, but not

1

2                 limited to, base rebates and reasonable estimates of

2

3                 any price protection rebates and performance-based

3

4                 rebates that may accrue, directly or indirectly, to

4

5                 the health insurer or pharmacy benefits manager as a

5

6                 result of point-of-sale prescription medication claims

6

7                 processing during the coverage year from a

7

8                 manufacturer, dispensing pharmacy, or other party to

8

9                 the transaction, or

9

10  b. reasonable estimates of any fees and other

10

11                administrative costs that are passed through to the

11

12                health insurer as a result of point-of-sale

12

13                prescription medication claims processing and serve to

13

14                reduce the health insurer's prescription medication

14

15                liabilities for the coverage year; and

15

16  13. "Provider contract" means any contract between a health

16

17 care provider and a health insurer, or an insurer's network,
17

18 provider panel, intermediary, or representative, relating to the
18

19 provision of health care services.
19

20  B. Any health insurer or pharmacy benefits manager that issues,

20

21 renews, or amends a health benefit plan with prescription drug
21

22 coverage shall not impose an excess cost burden on an insured.
22

23  C. When contracting with a health insurer or health benefit

23

24 plan to administer pharmacy benefits, a pharmacy benefits manager
24

    Req. No. 679                                               Page 4
1 shall offer the health benefit plan the option of extending point-
1

2 of-sale rebates to enrollees of the plan.
2

3   D. Prescription drug cost-sharing for an insured shall be the

3

4 lesser of:
4

5   1. The applicable copayment for the prescription medication

5

6 that would be payable in the absence of this section;
6

7   2. The maximum allowable cost;

7

8   3. The maximum allowable claim;

8

9   4. The adjusted out-of-pocket amount as determined pursuant to

9

10 this section;
10

11  5. The amount an insured would pay for the prescription

11

12 medication if the insured purchased it without using his or her
12

13 health benefit plan or any other source of prescription medication
13

14 benefits or discounts; or
14

15  6. The amount the pharmacy will be reimbursed for the

15

16 prescription medication by the health insurer or pharmacy benefits
16

17 manager.
17

18  E. The Insurance Commissioner shall promulgate rules to

18

19 effectuate the provisions of this section.
19

20  SECTION 3. This act shall become effective November 1, 2025.

20

21

21

22  60-1-679      CAD         12/17/2024 10:51:28 AM

22

23

23

24

24

    Req. No. 679                                           Page 5
Every fact on this page links to its source, starting with the official bill record.